Evnia proudly announces that our CEO Dr. Efstathios Vassiliadis will be speaking at the Riyadh Global Medical Biotechnology Summit (RGMBS 2024), held in the KSA’s capital from 10-12 November.
As an organisation, we prioritise healthcare innovation and actively work for the timely market access of medical products. These products aim to address unmet needs and healthcare deficiencies in emerging and developed regions. Building an ecosystem of biotechnology start-ups is essential to shaping proactive, preventive healthcare and state-of-the-art diagnostics and therapeutics within this context.
Being part of the RGMBS Summit and exchanging experiences and views with esteemed researchers, healthcare professionals, policymakers, and entrepreneurs is part of our vision to bridge the gaps between basic research, authorities, and investors!
Join us!
The event will be available via live streaming here.
